Does the media prefer SRTA or LFMD?

In the previous week, LifeMD had 10 more articles in the media than Strata Critical Medical. MarketBeat recorded 15 mentions for LifeMD and 5 mentions for Strata Critical Medical. Strata Critical Medical's average media sentiment score of 0.48 beat LifeMD's score of 0.17 indicating that Strata Critical Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Strata Critical Medical 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral LifeMD 0 Very Positive mention(s) 1 Positive mention(s) 8 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has stronger valuation and earnings, LFMD or VMD?

Viemed Healthcare has higher revenue and earnings than LifeMD. LifeMD is trading at a lower price-to-earnings ratio than Viemed Healthcare, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio LifeMD $194.05M 0.41 $14.35M -$0.05 N/A Viemed Healthcare $270.28M 1.28 $14.93M $0.38 23.97

Is LFMD or VMD more profitable?

Viemed Healthcare has a net margin of 5.03% compared to LifeMD's net margin of 0.10%. Viemed Healthcare's return on equity of 10.64% beat LifeMD's return on equity. Company Net Margins Return on Equity Return on Assets LifeMD 0.10% -168.23% -31.27% Viemed Healthcare 5.03% 10.64% 7.73%

Does the media favor LFMD or VMD?

In the previous week, LifeMD had 6 more articles in the media than Viemed Healthcare. MarketBeat recorded 15 mentions for LifeMD and 9 mentions for Viemed Healthcare. Viemed Healthcare's average media sentiment score of 0.37 beat LifeMD's score of 0.17 indicating that Viemed Healthcare is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment LifeMD 0 Very Positive mention(s) 1 Positive mention(s) 8 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral Viemed Healthcare 2 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts rate TACO or LFMD?

LifeMD has a consensus target price of $7.57, suggesting a potential upside of 357.49%. Given LifeMD's stronger consensus rating and higher possible upside, analysts plainly believe LifeMD is more favorable than Berto Acquisition. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Berto Acquisition 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 LifeMD 1 Sell rating(s) 1 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.70

Which has preferable valuation and earnings, TACO or LFMD?

LifeMD has higher revenue and earnings than Berto Acquisition. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Berto Acquisition N/A N/A N/A N/A N/A LifeMD $194.05M 0.41 $14.35M -$0.05 N/A

Does the media favor TACO or LFMD?

In the previous week, LifeMD had 11 more articles in the media than Berto Acquisition. MarketBeat recorded 15 mentions for LifeMD and 4 mentions for Berto Acquisition. Berto Acquisition's average media sentiment score of 1.39 beat LifeMD's score of 0.17 indicating that Berto Acquisition is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Berto Acquisition 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive LifeMD 0 Very Positive mention(s) 1 Positive mention(s) 8 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has stronger earnings & valuation, INFU or LFMD?

LifeMD has higher revenue and earnings than InfuSystem. LifeMD is trading at a lower price-to-earnings ratio than InfuSystem, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio InfuSystem $144.44M 2.07 $870K $0.45 32.87 LifeMD $194.05M 0.41 $14.35M -$0.05 N/A

Is INFU or LFMD more profitable?

InfuSystem has a net margin of 1.12% compared to LifeMD's net margin of 0.10%. InfuSystem's return on equity of 2.78% beat LifeMD's return on equity. Company Net Margins Return on Equity Return on Assets InfuSystem 1.12% 2.78% 1.41% LifeMD 0.10% -168.23% -31.27%

Does the media refer more to INFU or LFMD?

In the previous week, LifeMD had 11 more articles in the media than InfuSystem. MarketBeat recorded 15 mentions for LifeMD and 4 mentions for InfuSystem. LifeMD's average media sentiment score of 0.17 beat InfuSystem's score of 0.16 indicating that LifeMD is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment InfuSystem 0 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral LifeMD 0 Very Positive mention(s) 1 Positive mention(s) 8 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has higher earnings and valuation, BDSX or LFMD?

LifeMD has higher revenue and earnings than Biodesix. LifeMD is trading at a lower price-to-earnings ratio than Biodesix, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Biodesix $88.50M 1.23 -$35.26M -$2.76 N/A LifeMD $194.05M 0.41 $14.35M -$0.05 N/A

Is BDSX or LFMD more profitable?

LifeMD has a net margin of 0.10% compared to Biodesix's net margin of -25.74%. LifeMD's return on equity of -168.23% beat Biodesix's return on equity. Company Net Margins Return on Equity Return on Assets Biodesix -25.74% -442.34% -29.16% LifeMD 0.10% -168.23% -31.27%

Does the media favor BDSX or LFMD?

In the previous week, Biodesix had 13 more articles in the media than LifeMD. MarketBeat recorded 28 mentions for Biodesix and 15 mentions for LifeMD. LifeMD's average media sentiment score of 0.17 beat Biodesix's score of -0.03 indicating that LifeMD is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Biodesix 1 Very Positive mention(s) 3 Positive mention(s) 10 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Neutral LifeMD 0 Very Positive mention(s) 1 Positive mention(s) 8 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral

LifeMD (LFMD) Competitors

$2.02 +0.36 (+21.75%)

As of 12:34 PM Eastern

Compare

LFMD vs. SRTA, VMD, TACO, INFU, and BDSX

Should you buy LifeMD stock or one of its competitors? LifeMD's main competitors and comparable companies include Strata Critical Medical (SRTA), Viemed Healthcare (VMD), Berto Acquisition (TACO), InfuSystem (INFU), and Biodesix (BDSX). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare services" industry.

How does LifeMD compare to Strata Critical Medical?

Strata Critical Medical (NASDAQ:SRTA) and LifeMD (NASDAQ:LFMD) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, earnings, risk, dividends, analyst recommendations, media sentiment, institutional ownership and valuation.

In the previous week, LifeMD had 10 more articles in the media than Strata Critical Medical. MarketBeat recorded 15 mentions for LifeMD and 5 mentions for Strata Critical Medical. Strata Critical Medical's average media sentiment score of 0.48 beat LifeMD's score of 0.17 indicating that Strata Critical Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Strata Critical Medical	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral
LifeMD	0 Very Positive mention(s)	1 Positive mention(s)	8 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral

Strata Critical Medical presently has a consensus target price of $8.00, indicating a potential upside of 38.65%. LifeMD has a consensus target price of $7.57, indicating a potential upside of 357.49%. Given LifeMD's higher probable upside, analysts clearly believe LifeMD is more favorable than Strata Critical Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Strata Critical Medical	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.75
LifeMD	1 Sell rating(s)	1 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.70

Strata Critical Medical has higher revenue and earnings than LifeMD. Strata Critical Medical is trading at a lower price-to-earnings ratio than LifeMD, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Strata Critical Medical	$197.14M	2.59	$41.35M	-$0.03	N/A
LifeMD	$194.05M	0.41	$14.35M	-$0.05	N/A

47.4% of Strata Critical Medical shares are held by institutional investors. Comparatively, 35.5% of LifeMD shares are held by institutional investors. 15.5% of Strata Critical Medical shares are held by insiders. Comparatively, 17.2% of LifeMD shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Strata Critical Medical has a beta of 2.56, suggesting that its share price is 156% more volatile than the broader market. Comparatively, LifeMD has a beta of 2.19, suggesting that its share price is 119% more volatile than the broader market.

LifeMD has a net margin of 0.10% compared to Strata Critical Medical's net margin of -8.84%. Strata Critical Medical's return on equity of -2.71% beat LifeMD's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Strata Critical Medical	-8.84%	-2.71%	-2.31%
LifeMD	0.10%	-168.23%	-31.27%

Summary

Strata Critical Medical beats LifeMD on 11 of the 16 factors compared between the two stocks.

How does LifeMD compare to Viemed Healthcare?

LifeMD (NASDAQ:LFMD) and Viemed Healthcare (NASDAQ:VMD) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their media sentiment, profitability, valuation, institutional ownership, analyst recommendations, earnings, risk and dividends.

Viemed Healthcare has a net margin of 5.03% compared to LifeMD's net margin of 0.10%. Viemed Healthcare's return on equity of 10.64% beat LifeMD's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
LifeMD	0.10%	-168.23%	-31.27%
Viemed Healthcare	5.03%	10.64%	7.73%

Viemed Healthcare has higher revenue and earnings than LifeMD. LifeMD is trading at a lower price-to-earnings ratio than Viemed Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LifeMD	$194.05M	0.41	$14.35M	-$0.05	N/A
Viemed Healthcare	$270.28M	1.28	$14.93M	$0.38	23.97

LifeMD currently has a consensus price target of $7.57, suggesting a potential upside of 357.49%. Viemed Healthcare has a consensus price target of $12.00, suggesting a potential upside of 31.72%. Given LifeMD's stronger consensus rating and higher possible upside, research analysts clearly believe LifeMD is more favorable than Viemed Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LifeMD	1 Sell rating(s)	1 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.70
Viemed Healthcare	0 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.20

35.5% of LifeMD shares are owned by institutional investors. Comparatively, 74.2% of Viemed Healthcare shares are owned by institutional investors. 17.2% of LifeMD shares are owned by insiders. Comparatively, 20.6% of Viemed Healthcare shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

In the previous week, LifeMD had 6 more articles in the media than Viemed Healthcare. MarketBeat recorded 15 mentions for LifeMD and 9 mentions for Viemed Healthcare. Viemed Healthcare's average media sentiment score of 0.37 beat LifeMD's score of 0.17 indicating that Viemed Healthcare is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
LifeMD	0 Very Positive mention(s)	1 Positive mention(s)	8 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral
Viemed Healthcare	2 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

LifeMD has a beta of 2.19, indicating that its share price is 119% more volatile than the broader market. Comparatively, Viemed Healthcare has a beta of 1.05, indicating that its share price is 5% more volatile than the broader market.

Summary

Viemed Healthcare beats LifeMD on 11 of the 16 factors compared between the two stocks.

How does LifeMD compare to Berto Acquisition?

Berto Acquisition (NASDAQ:TACO) and LifeMD (NASDAQ:LFMD) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, risk, earnings, media sentiment, dividends, valuation and profitability.

LifeMD has higher revenue and earnings than Berto Acquisition.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Berto Acquisition	N/A	N/A	N/A	N/A	N/A
LifeMD	$194.05M	0.41	$14.35M	-$0.05	N/A

In the previous week, LifeMD had 11 more articles in the media than Berto Acquisition. MarketBeat recorded 15 mentions for LifeMD and 4 mentions for Berto Acquisition. Berto Acquisition's average media sentiment score of 1.39 beat LifeMD's score of 0.17 indicating that Berto Acquisition is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Berto Acquisition	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
LifeMD	0 Very Positive mention(s)	1 Positive mention(s)	8 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral

35.5% of LifeMD shares are held by institutional investors. 13.2% of Berto Acquisition shares are held by insiders. Comparatively, 17.2% of LifeMD shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

LifeMD has a consensus target price of $7.57, suggesting a potential upside of 357.49%. Given LifeMD's stronger consensus rating and higher possible upside, analysts plainly believe LifeMD is more favorable than Berto Acquisition.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Berto Acquisition	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
LifeMD	1 Sell rating(s)	1 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.70

Berto Acquisition has a beta of 0.07, indicating that its stock price is 93% less volatile than the broader market. Comparatively, LifeMD has a beta of 2.19, indicating that its stock price is 119% more volatile than the broader market.

LifeMD has a net margin of 0.10% compared to Berto Acquisition's net margin of 0.00%. Berto Acquisition's return on equity of 0.00% beat LifeMD's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Berto Acquisition	N/A	N/A	N/A
LifeMD	0.10%	-168.23%	-31.27%

Summary

LifeMD beats Berto Acquisition on 9 of the 12 factors compared between the two stocks.

How does LifeMD compare to InfuSystem?

InfuSystem (NYSE:INFU) and LifeMD (NASDAQ:LFMD) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, valuation, dividends, institutional ownership, analyst recommendations, risk, earnings and profitability.

71.1% of InfuSystem shares are held by institutional investors. Comparatively, 35.5% of LifeMD shares are held by institutional investors. 10.8% of InfuSystem shares are held by company insiders. Comparatively, 17.2% of LifeMD shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

InfuSystem has a beta of 1.38, indicating that its share price is 38% more volatile than the broader market. Comparatively, LifeMD has a beta of 2.19, indicating that its share price is 119% more volatile than the broader market.

In the previous week, LifeMD had 11 more articles in the media than InfuSystem. MarketBeat recorded 15 mentions for LifeMD and 4 mentions for InfuSystem. LifeMD's average media sentiment score of 0.17 beat InfuSystem's score of 0.16 indicating that LifeMD is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
InfuSystem	0 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
LifeMD	0 Very Positive mention(s)	1 Positive mention(s)	8 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral

LifeMD has higher revenue and earnings than InfuSystem. LifeMD is trading at a lower price-to-earnings ratio than InfuSystem, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
InfuSystem	$144.44M	2.07	$870K	$0.45	32.87
LifeMD	$194.05M	0.41	$14.35M	-$0.05	N/A

InfuSystem has a net margin of 1.12% compared to LifeMD's net margin of 0.10%. InfuSystem's return on equity of 2.78% beat LifeMD's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
InfuSystem	1.12%	2.78%	1.41%
LifeMD	0.10%	-168.23%	-31.27%

InfuSystem currently has a consensus price target of $17.50, suggesting a potential upside of 18.32%. LifeMD has a consensus price target of $7.57, suggesting a potential upside of 357.49%. Given LifeMD's higher probable upside, analysts plainly believe LifeMD is more favorable than InfuSystem.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
InfuSystem	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00
LifeMD	1 Sell rating(s)	1 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.70

Summary

InfuSystem and LifeMD tied by winning 8 of the 16 factors compared between the two stocks.

How does LifeMD compare to Biodesix?

Biodesix (NASDAQ:BDSX) and LifeMD (NASDAQ:LFMD) are both small-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, valuation, media sentiment, dividends, profitability, analyst recommendations, institutional ownership and risk.

LifeMD has higher revenue and earnings than Biodesix. LifeMD is trading at a lower price-to-earnings ratio than Biodesix, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Biodesix	$88.50M	1.23	-$35.26M	-$2.76	N/A
LifeMD	$194.05M	0.41	$14.35M	-$0.05	N/A

Biodesix has a beta of 0.65, suggesting that its share price is 35% less volatile than the broader market. Comparatively, LifeMD has a beta of 2.19, suggesting that its share price is 119% more volatile than the broader market.

21.0% of Biodesix shares are held by institutional investors. Comparatively, 35.5% of LifeMD shares are held by institutional investors. 23.2% of Biodesix shares are held by insiders. Comparatively, 17.2% of LifeMD shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

In the previous week, Biodesix had 13 more articles in the media than LifeMD. MarketBeat recorded 28 mentions for Biodesix and 15 mentions for LifeMD. LifeMD's average media sentiment score of 0.17 beat Biodesix's score of -0.03 indicating that LifeMD is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Biodesix	1 Very Positive mention(s)	3 Positive mention(s)	10 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Neutral
LifeMD	0 Very Positive mention(s)	1 Positive mention(s)	8 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral

Biodesix presently has a consensus target price of $34.20, indicating a potential upside of 249.34%. LifeMD has a consensus target price of $7.57, indicating a potential upside of 357.49%. Given LifeMD's higher probable upside, analysts clearly believe LifeMD is more favorable than Biodesix.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Biodesix	1 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.86
LifeMD	1 Sell rating(s)	1 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.70

LifeMD has a net margin of 0.10% compared to Biodesix's net margin of -25.74%. LifeMD's return on equity of -168.23% beat Biodesix's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Biodesix	-25.74%	-442.34%	-29.16%
LifeMD	0.10%	-168.23%	-31.27%

Summary

LifeMD beats Biodesix on 10 of the 17 factors compared between the two stocks.

Get LifeMD News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding LFMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

LFMD vs. The Competition

Export

Metric	LifeMD	Healthcare Providers & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$98.62M	$10.75B	$7.83B	$12.01B
Dividend Yield	N/A	2.54%	2.46%	4.50%
P/E Ratio	-40.91	35.64	34.41	30.36
Price / Sales	0.50	2.16	8.86	5.82
Price / Cash	N/A	23.62	22.23	22.80
Price / Book	4.20	3.67	4.39	3.77
Net Income	$14.35M	$335.01M	$3.51B	$390.55M
7 Day Performance	-14.98%	-1.42%	-1.68%	-0.58%
1 Month Performance	-18.42%	-1.64%	-4.09%	-6.84%
1 Year Performance	-56.39%	19.11%	0.66%	-6.12%

LifeMD Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
LFMD LifeMD	2.6538 of 5 stars	$2.02 +21.8%	$7.43 +268.7%	-67.4%	$98.62M	$194.05M	N/A	384	News Coverage Earnings Report Gap Up High Trading Volume
SRTA Strata Critical Medical	2.6929 of 5 stars	$4.78 +11.6%	$8.00 +67.5%	N/A	$425.44M	$255.98M	N/A	601	Gap Up
VMD Viemed Healthcare	4.1136 of 5 stars	$9.43 -2.4%	$14.00 +48.4%	+39.1%	$357.11M	$301.61M	26.05	1,382
TACO Berto Acquisition	1.497 of 5 stars	$10.50 +0.0%	N/A	+3.3%	$342.40M	N/A	N/A	7,892	Short Interest Decrease
INFU InfuSystem	2.5236 of 5 stars	$13.27 -4.1%	$17.50 +31.9%	+41.8%	$268.22M	$143.34M	221.54	473

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:LFMD) was last updated on 11/13/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

LifeMD (LFMD) Competitors

LFMD vs. SRTA, VMD, TACO, INFU, and BDSX

How does LifeMD compare to Strata Critical Medical?

Summary

How does LifeMD compare to Viemed Healthcare?

Summary

How does LifeMD compare to Berto Acquisition?

Summary

How does LifeMD compare to InfuSystem?

Summary

How does LifeMD compare to Biodesix?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

LFMD vs. The Competition

LifeMD Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

LifeMD (LFMD) Competitors

LFMD vs. SRTA, VMD, TACO, INFU, and BDSX

How does LifeMD compare to Strata Critical Medical?

Does the media prefer SRTA or LFMD?

Do analysts prefer SRTA or LFMD?

Which has better earnings and valuation, SRTA or LFMD?

Do institutionals and insiders believe in SRTA or LFMD?

Which has more risk & volatility, SRTA or LFMD?

Is SRTA or LFMD more profitable?

Summary

How does LifeMD compare to Viemed Healthcare?

Is LFMD or VMD more profitable?

Which has stronger valuation and earnings, LFMD or VMD?

Do analysts rate LFMD or VMD?

Do insiders & institutionals believe in LFMD or VMD?

Does the media favor LFMD or VMD?

Which has more risk and volatility, LFMD or VMD?

Summary

How does LifeMD compare to Berto Acquisition?

Which has preferable valuation and earnings, TACO or LFMD?

Does the media favor TACO or LFMD?

Do insiders & institutionals believe in TACO or LFMD?

Do analysts rate TACO or LFMD?

Which has more risk and volatility, TACO or LFMD?

Is TACO or LFMD more profitable?

Summary

How does LifeMD compare to InfuSystem?

Do insiders and institutionals believe in INFU or LFMD?

Which has more risk & volatility, INFU or LFMD?

Does the media refer more to INFU or LFMD?

Which has stronger earnings & valuation, INFU or LFMD?

Is INFU or LFMD more profitable?

Do analysts recommend INFU or LFMD?

Summary

How does LifeMD compare to Biodesix?

Which has higher earnings and valuation, BDSX or LFMD?

Which has more volatility & risk, BDSX or LFMD?

Do insiders and institutionals have more ownership in BDSX or LFMD?

Does the media favor BDSX or LFMD?

Do analysts rate BDSX or LFMD?

Is BDSX or LFMD more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

LFMD vs. The Competition

LifeMD Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools